Federated Hermes, Inc. Regulus Therapeutics Inc. Transaction History
Federated Hermes, Inc.
- $41.2 Billion
- Q2 2024
A detailed history of Federated Hermes, Inc. transactions in Regulus Therapeutics Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 12,852,654 shares of RGLS stock, worth $20.2 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
12,852,654
Previous 12,852,654
-0.0%
Holding current value
$20.2 Million
Previous $37 Million
37.85%
% of portfolio
0.06%
Previous 0.09%
Shares
4 transactions
Others Institutions Holding RGLS
# of Institutions
65Shares Held
52.6MCall Options Held
155KPut Options Held
34.2K-
Ra Capital Management, L.P. Boston, MA6.25MShares$9.81 Million0.17% of portfolio
-
Vivo Capital, LLC Palo Alto, CA5MShares$7.85 Million1.32% of portfolio
-
Octagon Capital Advisors LP New York, NY4.26MShares$6.69 Million1.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.05MShares$6.36 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.97MShares$6.23 Million0.0% of portfolio
About Regulus Therapeutics Inc.
- Ticker RGLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,634,400
- Market Cap $23M
- Description
- Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...